- Elsight (ELS) is chosen by Air Methods’ subsidiary, Spright to be its reliable link provider for different aerial vehicle platforms providing healthcare services across North America
- The company has signed a commercial partnership agreement and will integrate its Halo solution into all aircraft operated by Spright
- Further, the company will also become an official ‘Halo’ reseller in the US
- The first commercial order of Halo has been received upon signing the five-year agreement with Spright for an initial order value of US$90,000 (A$130,611)
- Shares in Elsight hold steady at 39.5 cents as of 1:18 pm AEST
Elsight (ELS) has been chosen by Air Methods’ subsidiary, Spright to be its reliable link provider for different manned and unmanned aerial vehicle platforms providing healthcare services across North America.
The company had signed a commercial partnership agreement with Air Methods and will integrate its Halo solution into all aircraft operated by Spright, including the Wingcopter 198 aircraft.
Further, the company will also become an official ‘Halo’ reseller in the US.
Under the reseller terms, Spright will also perform configuration and lifecycle management on the Halo at its US locations.
The first commercial order of Halo has been received upon signing the five-year agreement with Spright for an initial order value of US$90,000 (A$130,611).
Elsight CEO Yoav Amitai said the partnership agreement confirmed the company’s positioning of Halo as the ultimate drone and other unmanned connectivity solution.
“The flexibility inherent in the industry-agnostic ‘Halo’ means the various use cases being fielded by Spright will all be supported.
“The initial order is the launching pad for a relationship that is rapidly thriving and will continue to steadily grow.
“Elsight looks forward to further orders for ‘Halo’ as Spright continues to expand their drone operations.”
Spright’s goal is to be the largest drone operator in the medical delivery space, ensuring that they can set a network up across the entire United States to support their hospital partners, new partners, and laboratories to improve healthcare overall.
Elsight said this significant aspiration is expected to drive the strategic relationship with the company.
Shares in Elsight held steady at 39.5 cents as of 1:18 pm AEST.